Navigation Links
Warning Labels Update Survives Dismissal in Fosamax Multidistrict Litigation: Now, AttorneyOne Can Provide Advice
Date:8/23/2013

San Diego, CA (PRWEB) August 23, 2013

AttorneyOne.com, a recognized authority on law, updated the website recently and they are now actively providing expert opinion in view of the recent news on Fosamax lawsuits and potential Fosamax Class Action lawsuit.

On August 15, a New York federal judge ruled in Fosamax Multidistrict Litigation that generic manufacturers can be held liable for failing to match their warning labels to the brand name label (MDL 1789, U.S. District Court for the Southern District of New York). Fosamax, manufactured by Merck, belongs to the class of drugs known as bisphosphonates. It was approved by the FDA in 1995 and developed to treat post-menopausal osteoporosis and Paget's disease of bone.

According to court documents, on July 1st, a US Federal judge denied Merck’s attempt to wipe out a $285,000 plaintiff verdict on Fosamax jaw deterioration (case no. 1:08-cv-04119, U.S. District Court for the Southern District of New York). In the lawsuit, the plaintiff claims that she took Fosamax from 2000 to 2006 and, as a result, she suffers severe and permanent personal injuries to the jaw bone, including osteonecrosis of the jaw.

Taking into consideration the latest developments, AttorneyOne.com updated the website and, now, can actively provide an expert opinion including how to get in contact with legal counsel easily and inexpensively in case of alleged Fosamax severe complications. Sean Burke, director of Media Relations at AttorneyOne.com, adds that the relevant information illustrates that people continue to file Fosamax lawsuits. "For that reason," he continues, "our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”

Court documents updated on August 15, by the US Judicial Panel on Multidistrict Litigation, indicate that there are 978 actions pending in the Fosamax MDL No 1789.

AttorneyOne.com has further information on Fosamax lawsuits including how to get in contact with legal counsel.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2013/8/prweb11050301.htm .

Read the full story at http://www.prweb.com/releases/2013/8/prweb11054963.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Mental Health Watchdog Launches Psychiatric Drug Side Effects Database—Search All Drug Regulatory Agency Warnings, Studies & Adverse Reactions Reports
2. Injury Law Firm Releases New Informational Graphic Warning that Lead Poisoning is Still a Serious Risk in the United States
3. Zithromax Arrhythmia and Sudden Death Cases Allegations Update: Resource4thePeople Reports FDA Issued Warning Letter to Manufacturer over False and Misleading Information
4. AED.com Issues Warning to Consumers Concerning AED Scams
5. Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on Release of FDA Warning Letter to Intuitive Surgical
6. Vulcan Termite and Pest Control, Inc. Warning: Tiger Mosquito Invasion
7. Da Vinci Robot Lawsuits Continue as Alonso Krangle LLP Comments on Revelations in Intuitive Surgical Inc.’s FDA Warning Letter
8. Da Vinci Robot Lawsuit Lawyers at Wright & Schulte LLC Comment on FDA Warning Letter Received by Intuitive Surgical
9. Da Vinci Surgical Robot Lawsuit Update: Parker Waichman LLP Comments on FDA Warning Letter Sent to Intuitive Surgical Noting da Vinci Surgical Robot Deficiencies
10. Robotic Surgery Lawsuit News: Bernstein Liebhard LLP Comments on FDA Warning Letter to Intuitive Surgical Inc.
11. International Adhesions Society Renews Call for Pain Treatment Alternatives and Welcomes CDC Warnings about Alarming Prescription Drug Deaths in U.S. Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... ... Illustrate, Maintain® methodology and industry-leading compliance software, The Guard®, has helped another long-time ... Rights (OCR) HIPAA audit and properly satisfy the law. , Thanks to the ...
(Date:9/20/2017)... , ... September 20, 2017 , ... ... and social campaign, “Humans With Vaginas.” The goal is to ignite conversation via ... non-toxic personal care products. The brand has declared September “Humans with Vaginas” month, ...
(Date:9/20/2017)... ... 20, 2017 , ... Medicare doesn’t have the authority to ... for their prescription drugs, according to a new comparison of drug plans by ... behalf, there’s no consistency in drug pricing among drug plans,” states TSCL’s Medicare ...
(Date:9/20/2017)... ... September 20, 2017 , ... “The Trials I Face to Receive ... he emotionally pens his aspirations and goals to better one’s life through God. “The ... Green, while searching in all the wrong places, found a love for writing. Green ...
(Date:9/20/2017)... ... September 20, 2017 , ... Houston, Texas, investment firm CORDA Investment ... 8, and Monday, September 11, off work and rolled up their sleeves to help ... to local homes to start the process of rebuilding. , CORDA founder Bonner C. ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)...  Eli Lilly and Company (NYSE: LLY ... for lasmiditan, an investigational, oral, first-in-class molecule for the ... compared to placebo in the Phase 3 SPARTAN study. ... Congress of the International Headache Society (IHC) in ... today demonstrate lasmiditan,s potential to reduce pain and provide ...
(Date:9/7/2017)... , Sept. 7, 2017 Caris Life ... on fulfilling the promise of precision medicine, today ... the benefits of its molecular profiling approach in ... comprehensive genomic profiling plus (CGP+) with Caris Molecular ... tumor on a molecular level, leading to more ...
(Date:9/7/2017)... --  BioLife Solutions , Inc. (NASDAQ: BLFS ), ... cell and tissue hypothermic storage and cryopreservation ... President and CEO, will be presenting at two investment conferences ... 19 th Annual Global Investment Conference on Tuesday, September ... The conference is being held at the New York Palace ...
Breaking Medicine Technology: